Fibrinogen
Material: Blood
Test price: PLN 15.00
Waiting time for the result: the result will be available no later than the next business day
Reservation:
Test price: PLN 15.00
Waiting time for the result: the result will be available no later than the next business day
Reservation:
- Check the opening hours of the collection point and where an appointment is required.
Buy in e-Reservation »Buy without logging in »Check collection points »
Preparation for the examination
General
- The material for testing is blood.
- Approximately 30 minutes before the examination, it is recommended to drink 1 glass of water only.
- The patient must fast. On the day before the test, a light,
low-fat diet is recommended, along with refraining from intense physical activity and stimulants. - On the day of your blood test, you should avoid drinking coffee or smoking. It's recommended to drink a glass of water.
Rest for 15-20 minutes before your blood test.
Detailed for babies
- For children up to 3 years of age, it is recommended to collect blood half to one hour after feeding.
Description
Fibrinogen is synthesized in the liver and participates in clot formation.
Increased fibrinogen levels are seen in menstruation, pregnancy, nephrotic syndrome, glomerulonephritis, hemolytic uremic syndrome, acute febrile states, infectious diseases, major surgery, trauma, collagenoses (lupus erythematosus, periarteritis nodosa), paroxysmal nocturnal hemoglobinuria, neoplastic diseases, thrombotic thrombocytopenic purpura, and a risk factor for coronary artery disease.
Decreased levels are seen in congenital fibrinogen deficiency, liver disease, DIC, posthemorrhagic fibrinolytic diathesis, acute promyelocytic leukemia, neoplasms, and infectious mononucleosis.
Increased fibrinogen levels are seen in menstruation, pregnancy, nephrotic syndrome, glomerulonephritis, hemolytic uremic syndrome, acute febrile states, infectious diseases, major surgery, trauma, collagenoses (lupus erythematosus, periarteritis nodosa), paroxysmal nocturnal hemoglobinuria, neoplastic diseases, thrombotic thrombocytopenic purpura, and a risk factor for coronary artery disease.
Decreased levels are seen in congenital fibrinogen deficiency, liver disease, DIC, posthemorrhagic fibrinolytic diathesis, acute promyelocytic leukemia, neoplasms, and infectious mononucleosis.
Preparation and development of material (applies only to contractors)
1107
Fibrinogen,
